MALARIA ERADICATION
THROUGH VACCINATION
Sanaria's vaccines are intended to be used to prevent malaria in individuals and, in combination with other malaria control measures, to halt transmission of and eliminate malaria from communities.
The International PfSPZ Consortium met in Oxford on May 7, 2019
Thirty-three malaria experts gathered at the University of Oxford, with many more joining remotely, for the International PfSPZ Consortium meeting on May 7, 2019.
Sanaria’s CEO, Dr. Stephen L. Hoffman, testifies in front of the US Senate Committee on Small Business & Entrepreneurship
Dr. Hoffman testified in front on the Senate Committee on Small Business and Entrepreneurship: Reauthorization of the SBA’s Innovation Programs
Sanaria’s Team Participates in Rockville Science Day
Sanaria staff members: Hashani Hettiarachchi, Alyssa Arnheim, Maryam Hosseini, and Henry Huang), participated at the 30th Rockville Science Day on April 28, 2019.
Sanaria’s Team Participates in 2nd Annual Kimball STEAM Fair
Sanaria staff members: Ian McWilliams, Don Ward, Tobi Fagbohun, Henry Huang, and Sam Slavin visited Kimball Elementary for the 2nd annual Kimball STEAM fair on April 26, 2019.
Teams From the Universtiy of Bamako, Mali and the NIH Visit Sanaria
Teams from the Bamako Malaria Research Training Center, University of Bamako, Mali and the Laboratory of Immunology and Vaccinology, National Institutes of Allergy and Infectious Diseases, NIH visited Sanaria to discuss progress on our collaboration on 5 clinical trials in Mali and 2 clinical trials in the U.S. of PfSPZ Vaccine and PfSPZ-CVac.
Nature Magazine News: Promising malaria vaccine to be tested in first large field trial – Declan Butler
The vaccine can confer up to 100% protection and will be tested in 2,100 people on the west African island of Bioko.
An Urgent Need for Malaria Vaccines
Sanaria has an innovative approach to malaria vaccines using Plasmodium falciparum (Pf) sporozoites (SPZ) as the platform technology for immunizing people against malaria infection. The proven effective results of this approach are documented in Sanaria’s publications.
Global Collaboration: The I-PfSPZ Consortium
Semi-annually, Sanaria organizes the international PfSPZ Consortium (i-PfSPZ-C) meeting for our partners, collaborators and funders where we analyze, present and discuss our findings prior to publication. The i-PfSPZ-C allows our collaborators and partners to share their work, modify research and clinical plans based on the consortium efforts and map out future funding needs.
Subscribe
Our Malaria Vaccine Pipeline
Innovative routes to success. A major impact in global health.